Low frequency of anti-D alloimmunization following D+ platelet transfusion: The Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study

British Journal of Haematology

Volumn 168, Issue 4, 2015, Pages 598-603

  Cid, Joan ^a,b   Lozano, Miguel ^a   Ziman, Alyssa ^c   West, Kamille A ^b   O'Brien, Kerry L ^d   Murphy, Michael F ^e   Wendel, Silvano ^f   Vázquez, Alejandro ^g   Ortín, Xavier ^h   Hervig, Tor A ⁱ   Delaney, Meghan ^j   Flegel, Willy A ^b   Yazer, Mark H ^k  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e NHS BLOOD AND TRANSPLANT   (United Kingdom)

^f HOSPITAL SÍRIO LIBANÊS   (Brazil)

^g HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^h HOSPITAL VERGE DE LA CINTA   (Spain)

ⁱ HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^j UNIVERSITY OF WASHINGTON   (United States)

^k UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Alloimmunization; Anti D alloantibodies; D compatibility; Platelet transfusion; RhIG

Indexed keywords

RHESUS D ANTIBODY; ALLOANTIBODY; BLOOD GROUP ABO SYSTEM; BLOOD GROUP RHESUS SYSTEM; RHO(D) ANTIBODY;

ADOLESCENT; ADULT; AGE; AGED; ALLOIMMUNIZATION; ANTIBODY SCREENING; APHERESIS; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CHILD; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEOPLASM; RETROSPECTIVE STUDY; SEROLOGY; SEX DIFFERENCE; THROMBOCYTE TRANSFUSION; ADVERSE EFFECTS; BIOSYNTHESIS; BLOOD GROUP ABO SYSTEM; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUP RHESUS SYSTEM; CLINICAL TRIAL; IMMUNOLOGY; INCIDENCE; MIDDLE AGED; PARITY; PREGNANCY; PRESCHOOL CHILD; THROMBOCYTOPHERESIS; YOUNG ADULT;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; AGED; BLOOD GROUP INCOMPATIBILITY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; ISOANTIBODIES; MALE; MIDDLE AGED; PARITY; PLATELET TRANSFUSION; PLATELETPHERESIS; PREGNANCY; RETROSPECTIVE STUDIES; RH-HR BLOOD-GROUP SYSTEM; RHO(D) IMMUNE GLOBULIN; YOUNG ADULT;

EID: 84923035282     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13158     Document Type: Article

References (38)

1. AABB (2012) Standards for Blood Banks and Transfusion Services, 28th edn. AABB Press, Bethesda, MD.
2. Atoyebi, W., Mundy, N., Croxton, T., Littlewood, T.J. & Murphy, M.F. (2000) Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD-positive platelet concentrates? British Journal of Haematology, 111, 980-983.
3. Ayache, S. & Herman, J.H. (2008) Prevention of D sensitization after mismatched transfusion of blood components: toward optimal use of RhIG. Transfusion, 48, 1990-1999.
4. Baldwin, M.L., Ness, P.M., Scott, D., Braine, H. & Kickler, T.S. (1988) Alloimmunization to D antigen and HLA in D-negative immunosuppressed oncology patients. Transfusion, 28, 330-333.
5. Bartley, A.N., Carpenter, J.B. & Berg, M.P. (2009) D+ platelet transfusions in D- patients: cause for concern? Immunohematology, 25, 5-8.
6. Boctor, F.N., Ali, N.M., Mohandas, K. & Uehlinger, J. (2003) Absence of D- alloimmunization in AIDS patients receiving D-mismatched RBCs. Transfusion, 43, 173-176.
7. Cid, J. (2003) PLT transfusions from D+ blood donors to D-patients with hematologic diseases: am update. Transfusion, 43, 1759-1760.
8. Cid, J. & Lozano, M. (2005) Risk of Rh(D) alloimmunization after transfusion of platelets from D+ donors to D- recipients. Transfusion, 45, 453-454.
9. Cid, J., Ortin, X., Elies, E., Castella, D., Panades, M. & Martin-Vega, C. (2002) Absence of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions. Transfusion, 42, 173-176.
10. Cid, J., Lozano, M., Fernandez-Aviles, F., Carreras, E., Pereira, A., Mazzara, R. & Ordinas, A. (2006) Anti-D alloimmunization after D-mismatched allogeneic hematopoietic stem cell transplantation in patients with hematologic diseases. Transfusion, 46, 169-173.
11. Cid, J., Carbasse, G., Pereira, A., Sanz, C., Mazzara, R., Escolar, G. & Lozano, M. (2011) Platelet transfusions from D+ donors to D- patients: a 10-year follow-up study of 1014 patients. Transfusion, 51, 1163-1169.
12. Cid, J., Harm, S.K. & Yazer, M.H. (2013) Platelet transfusion - the art and science of compromise. Transfusion Medicine and Hemotherapy, 40, 160-171.
13. Cid, J., Lozano, M., Klein, H.G. & Flegel, W.A. (2014) Matching for the D antigen in haematopoietic progenitor cell transplantation: definition and clinical outcomes. Blood Transfusion, 12, 301-306.
14. Culibrk, B., Stone, E., Levin, E., Weiss, S., Serrano, K. & Devine, D.V. (2012) Application of the ADVIA cerebrospinal fluid assay to count residual red blood cells in blood components. Vox Sanguinis, 103, 186-193.
15. Dunstan, R.A., Simpson, M.B. & Rosse, W.F. (1984) Erythrocyte antigens on human platelets. Absence of Rh, Duffy, Kell, Kidd, and Lutheran antigens. Transfusion, 24, 243-246.
16. European Committee on Blood Transfusion (2010) Guide to the Preparation, Use and Quality Assurance of Blood Components, 16th edn, European Directorate for the Quality of Medicines, Strasbourg, France.
17. Frohn, C., Dumbgen, L., Brand, J.M., Gorg, S., Luhm, J. & Kirchner, H. (2003) Probability of anti-D development in D- patients receiving D+ RBCs. Transfusion, 43, 893-898.
18. Goldfinger, D. & McGinniss, M.H. (1971) Rh-incompatible platelet transfusions-risks and consequences of sensitizing immunosuppressed patients. New England Journal of Medicine, 284, 942-944.
19. Gonzalez-Porras, J.R., Graciani, I.F., Perez-Simon, J.A., Martin-Sanchez, J., Encinas, C., Conde, M.P., Nieto, M.J. & Corral, M. (2008) Prospective evaluation of a transfusion policy of D+ red blood cells into D- patients. Transfusion, 48, 1318-1324.
20. Gunson, H.H., Stratton, F. & Phillips, P.K. (1971) The use of modified cells to induce an anti-Rh response. British Journal of Haematology, 21, 683-694.
21. Heim, M.U., Bock, M., Kolb, H.J., Schleuning, M. & Mempel, W. (1992) Intravenous anti-D gammaglobulin for the prevention of rhesus isoimmunization caused by platelet transfusions in patients with malignant diseases. Vox Sanguinis, 62, 165-168.
22. Klein, H.G. & Anstee, D.J. (2005) Blood Transfusion in Clinical Medicine, 11th edn. Blackwell Publishing, London.
23. Lichtiger, B., Surgeon, J. & Rhorer, S. (1983) Rh-incompatible platelet transfusion therapy in cancer patients. A study of 30 cases. Vox Sanguinis, 45, 139-143.
24. Lozano, M. & Cid, J. (2003) The clinical implications of platelet transfusions associated with ABO or Rh(D) incompatibility. Transfusion Medicine Reviews, 17, 57-68.
25. McLeod, B.C., Piehl, M.R. & Sassetti, R.J. (1990) Alloimmunization to RhD by platelet transfusions in autologous bone marrow transplant recipients. Vox Sanguinis, 59, 185-189.
26. Menitove, J.E. (2002) Immunoprophylaxis for D- patients receiving platelet transfusions from D+ [correction of D-] donors? Transfusion, 42, 136-138.
27. Misso, S., Feola, B., Paesano, L., D'Onofrio, M., Fratellanza, G., D'Agostino, E., Nigro, M., Minerva, A. & Formisano, S. (2006) Anti-D alloimmunisation following Rh-incompatible platelet transfusions. Blood Transfusion, 4, 102-105.
28. Molnar, R., Johnson, R., Sweat, L.T. & Geiger, T.L. (2002) Absence of D alloimmunization in D- pediatric oncology patients receiving D-incompatible single-donor platelets. Transfusion, 42, 177-182.
29. Moncharmont, P., Barday, G. & Meyer, F. (2014) Red blood cell alloimmunisation after platelet transfusion: a 5-year study. Blood Transfusion, 12(Suppl. 1), s147-s148.
30. O'Brien, K.L., Haspel, R.L. & Uhl, L. (2014) Anti-D alloimmunization after D-incompatible platelet transfusions: a 14-year single-institution retrospective review. Transfusion, 54, 650-654.
31. Ramsey, G. & Larson, P. (1988) Loss of red cell alloantibodies over time. Transfusion, 28, 162-165.
32. Ramsey, G. & Smietana, S.J. (1994) Long-term follow-up testing of red cell alloantibodies. Transfusion, 34, 122-124.
33. Santana, J.M. & Dumont, L.J. (2006) A flow cytometric method for detection and enumeration of low-level, residual red blood cells in platelets and mononuclear cell products. Transfusion, 46, 966-972.
34. Schonewille, H., Haak, H.L. & van Zijl, A.M. (2000) RBC antibody persistence. Transfusion, 40, 1127-1131.
35. Tormey, C.A. & Stack, G. (2009) The persistence and evanescence of blood group alloantibodies in men. Transfusion, 49, 505-512.
36. Yazer, M.H. & Triulzi, D.J. (2007) Detection of anti-D in D- recipients transfused with D+ red blood cells. Transfusion, 47, 2197-2201.
37. Yuan, S., Davis, R., Lu, Q., Goldfinger, D. & Ziman, A.F. (2008) Low risk of alloimmunization to the D antigen in D- orthotopic liver transplant recipients receiving D+ RBCs perioperatively. Transfusion, 48, 2653-2655.
38. Zeiler, T., Wittmann, G., Zingsem, J., Weisbach, V., Zimmermann, R. & Eckstein, R. (1994) A dose of 100 IU intravenous anti-D gammaglobulin is effective for the prevention of RhD immunisation after RhD-incompatible single donor platelet transfusion. Vox Sanguinis, 66, 243.